Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Capital Leases (2019 - 2025)

Marimed (MRMD) has disclosed Capital Leases for 7 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Capital Leases rose 1.56% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, up 1.56% year-over-year, with the annual reading at $2.0 million for FY2025, 1.56% up from the prior year.
  • Capital Leases for Q4 2025 was $2.0 million at Marimed, down from $2.2 million in the prior quarter.
  • The five-year high for Capital Leases was $2.7 million in Q2 2024, with the low at $22000.0 in Q4 2021.
  • Average Capital Leases over 5 years is $1.3 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Capital Leases plummeted 50.55% in 2021, then soared 1995.45% in 2022.
  • Over 5 years, Capital Leases stood at $22000.0 in 2021, then skyrocketed by 1995.45% to $461000.0 in 2022, then surged by 364.21% to $2.1 million in 2023, then fell by 10.0% to $1.9 million in 2024, then increased by 1.56% to $2.0 million in 2025.
  • According to Business Quant data, Capital Leases over the past three periods came in at $2.0 million, $2.2 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.